THU553 Anti-tumor Effect Of Rosiglitazone Via Upregulating 15-PDGH In Prolactin Secreting Adenoma

Disclosure: C. Kang: None. J. Oh: None. E. Wang: None. S. Lee: None. J. Nam: None. J. Hong: None. E. Lee: None. C. Ku: None. Background: Rosiglitazone, a synthetic peroxisome proliferator-activated receptor γ (PPAR γ) ligand, are used to treat type II diabetes. Over the last few years, PPAR γ has re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Chan Woo, Hun OH, Ju, Wang, Eun Kyung, Lee, Soohyun, Nam, Jung Ho, Hong, Jae Won, Lee, Eun Jig, Ku, Cheol Ryong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554068/
http://dx.doi.org/10.1210/jendso/bvad114.2179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554068/
http://dx.doi.org/10.1210/jendso/bvad114.2179

Ejemplares similares